1. In Print in Falk Library: Neuroendocrinology. 2006;84(3):183-8. Epub 2007 Feb 20. Well-differentiated pancreatic tumor/carcinoma: insulinoma. de Herder WW, Niederle B, Scoazec JY, Pauwels S, Kloppel G, Falconi M, Kwekkeboom DJ, Oberg K, Eriksson B, Wiedenmann B, Rindi G, O’Toole D, Ferone D; Frascati Consensus Conference; European Neuroendocrine Tumor Society. Department of Internal Medicine, Section of Endocrinology, Erasmus MC, Rotterdam, The Netherlands. Consensus Development Conference Guideline
2. Curr Opin Oncol. 2008 Jan;20(1):25-33. Sporadically occurring functional pancreatic endocrine tumors: review of recent literature. Goldin SB, Aston J, Wahi MM.
3. Best Pract Res Clin Gastroenterol. 2005 Oct;19(5):783-98. Insulinoma. Grant CS.
4. Eur J Endocrinol. 2005 May;152(5):757-67. Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies. Vezzosi D, Bennet A, Rochaix P, Courbon F, Selves J, Pradere B, Buscail L, Susini C, Caron P.
5. Ann Surg. 2008 Jan;247(1):165-72. Improved contemporary surgical management of insulinomas: a 25-year experience at the Massachusetts General Hospital. Nikfarjam M, Warshaw AL, Axelrod L, Deshpande V, Thayer SP, Ferrone CR, Fernández-del Castillo C.
6. Endocrinol Metab Clin North Am. 1999 Sep;28(3):533-54. Surgical aspects of hyperinsulinemic hypoglycemia. Grant CS.